SFU
ANAC

Stonehage Fleming (UK)’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Stonehage Fleming (UK)’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-442
Closed -$14K – 322
2014
Q4 		$14K Buy
+442
New +$13.3K 0.01% 280

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Stonehage Fleming (UK)'s ANAC Position: Q1 2015 in Review

Stonehage Fleming (UK) sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2015, closing a stake of 442 shares — an estimated $14K sold.

Stonehage Fleming (UK) first reported a position in ANAC in Q4 2014 and held it in 1 quarter. The position peaked at $14K in Q4 2014. 157 funds tracked by Wall St. Rank hold ANAC as of Q1 2015.

  • Stonehage Fleming (UK) reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2015 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 442 ANACOR PHARMACEUTICALS INC COM shares in Q1 2015, an estimated $14K.
  • Stonehage Fleming (UK) first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 1 quarter.
  • Stonehage Fleming (UK)'s ANACOR PHARMACEUTICALS INC COM position peaked at $14K in Q4 2014.
  • 157 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q1 2015, filed 11 Oct 2019.